SEC Form 4 · accession 0001477932-26-003809
Cosmos Health Inc. · COSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anastasios Aslidis
Director
Period of report
May 19, 2026
Accepted (ET)
Jun 11, 2026 · 5:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001474167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.001 | May 19, 2026 | A | 40,000 | $0.283 | A | 100,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | — | May 19, 2026 | C | 40,000 | D | May 19, 2026 | May 19, 2036 | Common Stock, par value $.001 | 40,000 | 0 | D |
Explanation of responses
- F1Reflects the award of 40,000 shares of Common Stock granted on May 19, 2026, pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan, in a transaction exempt under Rule 16b-3.
- F2The RSUs were granted on May 19, 2026, under the Issuer's 2024 & 2025 Omnibus Incentive Plan and vested on the date of the grant, in a transaction exempt under Rule 16b-3.